Kilitch Healthcare India voluntarily recalls OTC eye drop products

November 21, 2023

1 min read


We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].

Kilitch Healthcare India Limited has voluntarily recalled 25 over-the-counter eye drop products after the FDA warned of unsanitary conditions and potential safety concerns, according to a company press release.

The recalled products with retailer name, which include those with expiration dates ranging from November 2023 to September 2025, are:



Image of a brown eye.

Kilitch Healthcare India Limited has voluntarily recalled 25 eye drop products due to potential safety concerns. Image: Adobe Stock

  • Lubricating Tears Eye Drops 15 mL (Rugby)
  • Polyvinyl Alcohol 1.4% Lubricating Eye Drops 15 mL (Rugby)
  • High Performance Lubricant Eye Drops 15 mL single and twin packs (Target)
  • Multi-Action Relief Drops 15 mL (Rite Aid)
  • Lubricating Gel Drops 10 mL (Rite Aid)
  • Lubricant Eye Drops 15 mL twin pack (Rite Aid)
  • Eye Irritation Relief 15 mL (Leader)
  • Dry Eye Relief 10 mL and 15 mL (Leader)
  • Lubricant Eye Drops 10 mL and 15 mL single and twin packs (Leader)
  • Lubricant Eye Drop 10 mL triple pack (Velocity)
  • Lubricant Eye Drops 10 mL single and twin packs and 15 mL single and twin packs (CVS)
  • Lubricant Gel Drops 10 mL and 15 mL single and twin packs (CVS)
  • Multi Action Relief Drops 15 mL (CVS)
  • Mild Moderate Lubricating Eye Drops 15 mL (CVS)
  • Dry Eye Relief 15 mL twin pack (Target)
  • Equate Hydration PF Lubricant Eye Drops 10 mL (Walmart)

Kilitch Healthcare has notified its distributor, Velocity Pharma, which will notify the retailers and wholesalers of the recall via mail and arrange for return of all affected products.

Consumers should stop using the recalled products and contact their health care provider if they experience any problems related to use of the products. While Kilitch Healthcare has received no reports of adverse reactions related to the recall, the company urges consumers and medical professionals to report adverse events to MedWatch, the FDA’s Safety Information and Adverse Event Reporting Program.

link

Leave a Reply

Your email address will not be published. Required fields are marked *